FDA Approved: KRINTAFEL — Supplemental Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved a supplemental application for Krintafel (tafenoquine) submitted by GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• KRINTAFEL (tafenoquine succinate)

Snippet

SUPPL AP for KRINTAFEL (TAFENOQUINE SUCCINATE)